Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first-quarter profit.The...
The American Heart Assn. calls them “game changers.”Oprah Winfrey says they’re “a gift.”Science magazine anointed them the “2023 Breakthrough of the Year.”Americans...